EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
NeuroOne Medical Technologies Corporation (NMTC) had EBIT Margin of -50.02% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$2.74M |
|
$-1.62M |
|
$1.21M |
|
$1.53M |
|
$4.11M |
|
$-1.37M |
|
$-0.25M |
|
$-1.62M |
|
$-1.62M |
|
$-1.62M |
|
$-1.62M |
|
$-1.62M |
|
$-1.62M |
|
$-1.37M |
|
$-1.31M |
|
40.15M |
|
40.15M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$10.23M |
|
$0.26M |
|
$0.56M |
|
$10.79M |
|
$2.30M |
|
-- |
|
$1.41M |
|
$3.71M |
|
$7.07M |
|
$7.03M |
|
$7.07M |
|
50.01M |
|
| Cash Flow Statement Financials | |
$-2.84M |
|
$-0.08M |
|
$8.03M |
|
$1.46M |
|
$6.57M |
|
$5.11M |
|
$1.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
55.77% |
|
-50.02% |
|
|
EBIT Margin |
-50.02% |
-- |
|
-59.08% |
|
-59.08% |
|
$-2.92M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.54 |
|
2.17 |
|
41.53 |
|
-22.89% |
|
-23.04% |
|
-15.01% |
|
-22.89% |
|
$0.14 |
|
$-0.07 |
|
$-0.07 |
|